Related Experiment Video

Updated: Mar 31, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
13:04

A Protocol for Analyzing Hepatitis C Virus Replication

Published on: June 26, 2014

24.8K

Current Management of Hepatitis C Virus: Regimens for Peri-Liver Transplant Patients

Varun Saxena1, Norah Terrault1

  • 1Division of Gastroenterology and Hepatology, Department of Medicine, University of California, San Francisco, San Francisco, CA, USA.

Clinics in Liver Disease
|October 16, 2015
PubMed

Insights

Treating chronic hepatitis C virus (HCV) before or after liver transplant is crucial for improving patient survival. This review examines challenges in managing HCV in transplant candidates and recipients.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Virology

Background:

  • Chronic hepatitis C virus (HCV) infection is the primary reason for liver transplantation in the U.S.
  • Recurrent HCV post-transplant significantly reduces graft and patient survival.
  • Progressive recurrent HCV disease is a major cause of graft failure.

Purpose of the Study:

  • To review current strategies for treating HCV in liver transplant candidates and recipients.
  • To highlight the challenges associated with peri-transplant HCV management.
  • To emphasize the importance of successful HCV treatment for post-transplant outcomes.

Main Methods:

  • Review of existing literature on HCV treatment in the peri-transplant period.
  • Analysis of clinical experience with wait-listed patients and transplant recipients.
  • Discussion of unique challenges in managing HCV in this specific population.

Main Results:

  • Recurrent HCV infection is nearly universal in viremic patients undergoing liver transplant.
  • Peri-transplant HCV treatment is essential for improving graft and patient survival rates.
  • Specific challenges exist in treating HCV in both pre- and post-transplant settings.

Conclusions:

  • Effective management of HCV in the peri-transplant period is critical for successful liver transplantation.
  • Addressing HCV before or after transplant can mitigate disease progression and improve long-term outcomes.
  • Further research and optimized treatment protocols are needed for this vulnerable patient group.

Keywords:
Cholestatic hepatitisDirect-acting antiviralsHepatitis C virusLedipasvirLiver transplantRecurrent hepatitis C virusSimeprevirSofosbuvir

More Related Videos

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies11:25

Heterotopic Auxiliary Whole Liver Rat Transplant Model Utilizing a Hepaticoureterostomy for Allograft Rejection Studies

Published on: March 8, 2024

985
Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection06:00

Laparoscopic Anatomic S7+S8d Resection Preserving Inferior Right Hepatic Vein and S6 with Right Hepatic Vein Transection

Published on: December 30, 2025

509

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
37
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
573
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
792
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
257